Novel biomarkers, such as NGAL, TIMP-2, IGFBP7, KIM-1, hemojuvelin, osteopontin, associated with the risk of AKI have been reported in previous studies [53,76–78]. Here, IGFBP7 is linked to acute kidney injury.